Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC)

Q: What does CUSIP 68622P109 represent in this 13F holders report?

CUSIP 68622P109 is the security identifier for ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

82 institutional investors reported ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 68622P109

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 97,866,034
Total 13F shares: 35,685,685
Share change: +3,077,832
Total reported value: $874,284,848
Price per share: $24.50
Number of holders: 82
Value change: +$71,774,159
Number of buys: 49
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 68622P109?
CUSIP 68622P109 identifies ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 68622P109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.6%	5,452,347	$184,562,000	—	31 Dec 2020	13F
Column Group LLC	13F	Company	4.9%	4,768,181	$161,403,000	—	31 Dec 2020	13F
EcoR1 Capital, LLC	13F	Company	3.2%	3,092,218	$104,672,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	3%	2,921,967	$98,909,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	1.9%	1,878,908	$63,602,000	—	31 Dec 2020	13F
Euclidean Capital LLC	13F	Company	1.4%	1,400,435	$47,405,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.1%	1,100,293	$37,245,000	—	31 Dec 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.1%	1,052,879	$35,640,000	—	31 Dec 2020	13F
Invus Financial Advisors, LLC	13F	Company	1%	1,007,575	$34,106,000	—	31 Dec 2020	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.92%	898,061	$30,399,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.89%	867,551	$29,366,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.87%	853,806	$28,901,000	—	31 Dec 2020	13F
Sloan Kettering Cancer Center Memorial	13F	Individual	0.62%	602,272	$20,387,000	—	31 Dec 2020	13F
Casdin Capital, LLC	13F	Company	0.61%	601,515	$20,361,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.6%	584,000	$19,768,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.53%	523,480	$17,720,000	—	31 Dec 2020	13F
EMERALD ADVISERS, LLC	13F	Company	0.53%	522,302	$17,680,000	—	31 Dec 2020	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.5%	488,234	$16,527,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.44%	430,000	$14,556,000	—	31 Dec 2020	13F
Ally Bridge Group (NY) LLC	13F	Company	0.42%	413,061	$13,982,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.37%	359,043	$12,154,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	314,500	$10,645,000	—	31 Dec 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.26%	252,910	$8,561,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	0.25%	248,898	$8,425,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.24%	237,047	$8,024,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	0.2%	200,000	$6,770,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.19%	182,200	$6,167,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	109,713	$3,714,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	101,862	$3,448,000	—	31 Dec 2020	13F
Artal Group S.A.	13F	Company	0.1%	100,000	$3,385,000	—	31 Dec 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.1%	97,194	$3,290,000	—	31 Dec 2020	13F
Laurion Capital Management LP	13F	Company	0.1%	96,536	$3,268,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.08%	73,731	$2,496,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.07%	67,996	$2,302,000	—	31 Dec 2020	13F
Asymmetry Capital Management, L.P.	13F	Company	0.07%	67,210	$2,275,000	—	31 Dec 2020	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.05%	53,000	$1,789,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.05%	49,455	$1,674,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.04%	40,600	$1,374,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	40,435	$1,369,000	—	31 Dec 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.04%	34,685	$1,174,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	33,559	$1,136,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.03%	31,209	$1,056,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	27,694	$937,000	—	31 Dec 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.03%	26,841	$909,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	24,800	$839,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	21,992	$744,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.02%	21,322	$722,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	18,400	$623,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	17,822	$603,000	—	31 Dec 2020	13F
BEACON INVESTMENT ADVISORY SERVICES, INC.	13F	Company	0.02%	17,556	$594,000	—	31 Dec 2020	13F

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q1 2021

As of 31 Mar 2021, Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,685,685 shares. The largest 10 holders included FMR LLC, The Column Group LLC, EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., STATE STREET CORP, Point72 Asset Management, L.P., VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, and JENNISON ASSOCIATES LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.